We are live on
!
Find out more
PCM
Penserra Capital Management Portfolio holdings
AUM
$8.52B
1-Year Est. Return
37.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$984M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$64.8M |
| 2 |
JD.com
JD
|
+$44.9M |
| 3 |
Mercado Libre
MELI
|
+$40.5M |
| 4 |
NetEase
NTES
|
+$38M |
| 5 |
KE Holdings
BEKE
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Futu Holdings
FUTU
|
+$21.6M |
| 2 |
Trip.com Group
TCOM
|
+$20.5M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
+$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
+$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.21% |
| 2 | Technology | 22.71% |
| 3 | Communication Services | 13.35% |
| 4 | Financials | 4.97% |
| 5 | Industrials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
851
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $40K | ﹤0.01% |
3,255
-15
| -0.5% | -$202 |
|
|
VAR
852
DELISTED
Varian Medical Systems, Inc.
VAR
| $40K | ﹤0.01% |
229
+37
| +19% | +$6.51K |
|
|
PAND
853
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $40K | ﹤0.01% |
670
-30
| -4% | -$1.09K |
|
854
Cincinnati Financial
CINF
$27.1B
| $39K | ﹤0.01% |
388
+60
| +18% | +$5.75K |
|
855
Gartner
IT
$11.7B
| $39K | ﹤0.01% |
215
+32
| +17% | +$5.56K |
|
856
Omnicom Group
OMC
$23.4B
| $39K | ﹤0.01% |
532
+80
| +18% | +$5.52K |
|
857
SS&C Technologies
SSNC
$18.6B
| $39K | ﹤0.01% |
567
+88
| +18% | +$5.94K |
|
858
Zentalis Pharmaceuticals
ZNTL
$302M
| $39K | ﹤0.01% |
915
-15
| -2% | -$646 |
|
859
Cable One
CABO
$212M
| $38K | ﹤0.01% |
21
+8
| +62% | +$15.6K |
|
860
IDEX
IEX
$17.3B
| $38K | ﹤0.01% |
184
+26
| +16% | +$5.16K |
|
861
Krystal Biotech
KRYS
$9.66B
| $38K | ﹤0.01% |
500
+50
| +11% | +$3.63K |
|
862
Scholar Rock
SRRK
$6.44B
| $38K | ﹤0.01% |
765
-5
| -0.6% | -$277 |
|
|
DRE
863
DELISTED
Duke Realty Corp.
DRE
| $38K | ﹤0.01% |
930
+144
| +18% | +$5.81K |
|
|
ENDP
864
DELISTED
Endo International plc
ENDP
| $38K | ﹤0.01% |
5,215
-130
| -2% | -$1.05K |
|
865
Arch Capital
ACGL
$33.6B
| $37K | ﹤0.01% |
987
+152
| +18% | +$5.41K |
|
866
Aurinia Pharmaceuticals
AUPH
$2.11B
| $37K | ﹤0.01% |
2,885
-55
| -2% | -$798 |
|
867
Castle Biosciences
CSTL
$979M
| $37K | ﹤0.01% |
555
+95
| +21% | +$7.14K |
|
868
Cytokinetics
CYTK
$10.4B
| $37K | ﹤0.01% |
1,605
-20
| -1% | -$427 |
|
869
Raymond James Financial
RJF
$34B
| $37K | ﹤0.01% |
461
+72
| +19% | +$5.37K |
|
|
ZEN
870
DELISTED
ZENDESK INC
ZEN
| $37K | ﹤0.01% |
285
+44
| +18% | +$6.3K |
|
|
FPRX
871
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $37K | ﹤0.01% |
990
-75
| -7% | -$1.87K |
|
872
Alector
ALEC
$199M
| $36K | ﹤0.01% |
1,800
-40
| -2% | -$717 |
|
873
Boston Properties
BXP
$11.1B
| $36K | ﹤0.01% |
358
+56
| +19% | +$5.46K |
|
|
GBIO
874
DELISTED
Generation Bio
GBIO
| $35K | ﹤0.01% |
123
+15
| +14% | +$4.8K |
|
875
Genmab
GMAB
$19.5B
| $35K | ﹤0.01% |
1,080
+5
| +0.5% | +$188 |
|
Similar funds
GRQ
IC
NB
DM
ACM
FT
NW
AAF
Penserra Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.
- Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
- Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
- Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
- Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
- Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
- Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
- Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.
Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.